Supernus Pharmaceuticals | SUPN - Ação





Ação Alterar Data
Abbott USD 6.99B 501M 2026-03
ANI Pharmaceuticals USD 143.47M 401K 2026-03
Aurora Cannabis CAD 230.56M 8.6M 2025-12
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Canopy Growth CAD 105.56M 3.18M 2025-12
Cara Therapeutics USD 900K 0 2025-03
Corcept Therapeutics USD 12.89M 22K 2026-03
Eisai JPY 236.46B 9.14B 2025-09
Eli Lilly USD 14.53B 785M 2026-03
Novo Nordisk DKK 45.65B 21.26B 2025-06
Pacira USD 150.37M 2.49M 2026-03
Perrigo USD 1.12B 27.6M 2026-03
Pfizer USD 10.67B 13M 2026-03
Supernus Pharmaceuticals USD 110.77M 1.71M 2026-03
United Therapeutics USD 178.3M 4.8M 2026-03
Xeris Pharmaceuticals USD 74.23M 5.56M 2026-03